Sign in Subscribe
Cancer research

Diagnostic and Prognostic Accuracy of MMPs and TIMPs in Oral Cancer

Strategic Insights

— 1 min read

Research from the Postgraduate Institute of Medical Education and Research in Chandigarh, India, has shed light on the role of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in oral cancer diagnosis and prognosis. The study aimed to analyze the expression of MMPs (MMP-1, MMP-3, MMP-9, and MMP-13) and TIMPs (TIMP-1 and TIMP-3) in oral cancer patients compared to healthy controls, and to evaluate the diagnostic accuracy of MMPs and TIMPs using enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry (IHC).

Key Takeaways:

  • Oral cancer is a significant noncommunicable disease burden in India, with molecular markers such as MMPs and TIMPs being researched for diagnostic and prognostic purposes.
  • The present study found that MMPs and TIMPs were more highly expressed in oral cancer patients compared to healthy controls, with MMP-13 showing the most significant difference.
  • MMP-3 and MMP-13 exhibited the highest sensitivity and specificity on ELISA, making them reliable diagnostic markers for oral cancer.
  • MMP-9 expressed the highest levels at advanced stages of oral cancer, making it a potential prognostic marker.
  • The study's findings suggest that MMP-9 and MMP-13 can be used as diagnostic markers, while MMP-9 is also a potential prognostic marker for oral cancer.

Statistics:

  • The study included 15 oral cancer patients and 14 healthy controls.
  • The mean age of the patients was 47.07 ± 15.74 years.
  • 86.7% of the patients were male.
  • MMP-3 and MMP-13 exhibited the highest sensitivity (95.8% and 85.7%, respectively) on ELISA.
  • TIMP-1 and MMP-13 exhibited the highest specificity (100% and 92.9%, respectively) on ELISA.
  • MMP-9 expressed the highest levels at advanced stages of oral cancer (IHC, 91.4% ± 9.4%).

Sources:

  • Postgraduate Institute of Medical Education and Research Reports Findings in Oral Cancer [Diagnostic and Prognostic Accuracy of MMPs and TIMPs in Oral Cancer Patients on Enzyme-Linked Immunosorbent Assay (ELISA) as Compared to Immunohistochemistry (IHC)]. Chemicals & Chemistry. May 23, 2025; p 2720.
  • Indian Journal of Surgical Oncology, 2024;16(2):601-610. (Springer - www.springer.com; Indian Journal of Surgical Oncology - www.springerlink.com/content/0975-7651/)

Read more